Key points are not available for this paper at this time.
Our results demonstrate that KLRC1 knockout is an effective strategy to improve NK cell antitumor activity against HLA-E+ tumors and could be applied in the development of NK cell therapy for solid tumors.
Donald et al. (Mon,) studied this question.